Corriente Advisors logo

Corriente Advisors

North America, Texas, United States, Fort Worth

Description

An Employee owned hedge fund sponsor

Investor Profile

Corriente Advisors has made 3 investments, with 1 in the past 12 months and 33% as lead.

Stage Focus

  • Seed (33%)
  • Series Unknown (33%)
  • Series A (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Manufacturing
  • Semiconductor
  • Sensor
  • Biotechnology
  • Genetics
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Corriente Advisors frequently co-invest with?

BO
Europe, England, United Kingdom, London
Co-Investments: 1
Palisade Capital Management
North America, New Jersey, United States, Fort Lee
Co-Investments: 1
Emerging Ventures
North America, California, United States, Los Angeles
Co-Investments: 1
General Electric Pension Trust
North America, Texas, United States, Austin
Co-Investments: 1
StratMinds
North America, California, United States, San Francisco
Co-Investments: 1
10X Capital
North America, New York, United States, New York
Co-Investments: 1
L'ATTITUDE Ventures
North America, California, United States, San Diego
Co-Investments: 1

Which angels does Corriente Advisors often collaborate with?

JR
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Corriente Advisors?

Omnitron Sensors

Los Angeles, California, United States

Omnitron Sensors develops and manufactures sensors for various applications, including automotive, augmented reality, and smartphones.

ManufacturingSemiconductorSensor
Series AJan 30, 2025
Amount Raised: $13,000,000
Omnitron Sensors

Los Angeles, California, United States

Omnitron sensors provides sensor technology.

ManufacturingSemiconductorSensor
SeedMay 15, 2021
Amount Raised: $2,400,000
Neurologix

Fort Lee, New Jersey, United States

Neurologix is engaged in the discovery and development of therapeutic treatments for disorders of the brain and central nervous system.

BiotechnologyGeneticsMedicalTherapeutics
Series UnknownDec 6, 2010
Amount Raised: $7,000,000